# Tumor Molecular Profiling in Patients With Prostate Cancer

> **NCT05573789** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 220 (actual)

## Conditions studied

- Prostate Cancer
- Metastatic Prostate Adenocarcinoma

## Interventions

- **GENETIC:** Tumor molecular profiling

## Key facts

- **NCT ID:** NCT05573789
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-09-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2022-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573789, "Tumor Molecular Profiling in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05573789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*